Abstract library

Introduction: Cooperative Group for NET was established on 22 April 2008. It continues with the practices of the Czech Carcinoid Group since 1998. The real incidence of neuroendocrine tumors is unknown. The majority remain undiagnosed. Therefore, the Czech Registry started in October 2009 to identify NET patients and to facilitate the diagnosis and therapy in centers with NET experts.

Introduction: Merkel cell carcinoma (MCC) is rare and aggressive neuroendocrine tumor. The incidence is increasing worldwide, most probably due to population aging (mostly in the Western Europe), higher rates of sun exposure, immunosuppression and other not well defined epigenetic changes.

Introduction: Gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) represent a group of uncommon, but clinically significant diseases. The data published so far have shown significant regional differences in their incidence and appearance in individual primary sites.

Notice

WARNING – FRAUDULENT WEBSITES

ENETS is aware that its members have been confronted with fake websites, which seem to relate to our congress but have not been commissioned or authorised by us. The websites offer fraudulent hotel reservation services. We therefore strongly recommend that you please only use the official enetsconference.org website when booking your tickets and accommodation. Please be vigilant when it comes to providing your credit card details.

If you have any questions, please do not hesitate to contact us at info@enets.org.

Important notice: Our privacy policy has been updated. Please click on the link in order to read our current privacy policy including information about the collection and use of data, with a special focus on the use of Google analytics, by ENETS.